Source NICE:
Alemtuzumab for the treatment of relapsing-remitting multiple sclerosis. Read more here.
PIP reassessments delayed
Source MS Society:
The DWP has announced it will delay, until 28 October 2013, the roll out of face to face benefits assessments for people moving from DLA to Personal Independence Payments.
The MS Society is calling for an end to the 20 metre rule for the enhanced rate mobility component of the benefit. Read more here.
The MS Society Short Breaks & Activities Fund
The MS Society’s Short Breaks and Activities (SBA) Fund provides financial support to people affected by MS. The fund can consider grants for people with MS and their carers to help them access a broad range of short breaks and activities.
MS Society Short Breaks booklets available at the centre, for more info go to www.mssociety.org.uk/ms-support/practical-and-financial-help/short-breaks-holidays-respite-care
Charity Flowers
We have joined Charity Flowers which means that The Centre receives 15% on all orders.
Our source code MSTCO must be quoted on all telephone orders to ensure that commission is received.
So next time you order flowers for loved ones, family and friends please order through this site.
Please go to www.charityflowers.co.uk
ILC Open Day Wed 2 Oct 2013
Stairs and Steps
- Are you less confident on the stairs?
- Do you get tired walking up stairs?
- Would you like to see different stair lifts?
- Can you manage outdoor steps?
At Peachcroft Christian Centre, Lindsay Drive, Abingdon OX14 2RT
All welcome. Drop in for coffee.
ILC Open Day – 4th September 2013
The ILC Open Day “Seating Options” will take place on Wed 4th of September At The Peachcroft Centre. All Welcome. Light snacks tea and coffee will be available to attendees.
Change of venue for ILC Open Days to Peachcroft Christian Centre for the foreseeable future.
Lindsay Drive, Abingdon, OX14 2RT
August 100 Club winners
Congratulations to the July 100 Club winners:-
1st prize, Glady’s Marr
2nd prize, Julia Gower
3rd prize, David Harsant
FDA Approves Stem Cell Clinical Trial For Multiple Sclerosis
Source Reuters:
NEW YORK, Aug. 14, 2013 /PRNewswire/ — The Tisch MS Research Center of New York announced today that it has received Investigational New Drug (IND) approval from the Food and Drug Administration (FDA) to commence a Phase 1 trial using autologous neural stem cells in the treatment of multiple sclerosis (MS). MS is a chronic human autoimmune disease of the central nervous system that leads to myelin damage and neurodegeneration and affects approximately 2.1 million people worldwide. Read more here.
Short breaks, respite care and holidays
Source MS Society:
The MS Society is now working with two organisations to make it easier for people with MS and their families and carers to access a range of short breaks, respite care and holidays.
The Park Club – Milton Park
The Park Club, Milton Park are offering all members, volunteer and employees of the OMSTC monthly membership at £24.99 (minimum 1 year).
Please let Sue know if you are interested and she will give you the details on how to join.
